FDA Inspection 1079073 — Lucasti Christopher, D.O.

Lucasti Christopher, D.O. — FEI 3003249248

The FDA completed an inspection of Lucasti Christopher, D.O. on Jan 25, 2019 in Somers Point, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Somers Point, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.